BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28138817)

  • 1. Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre.
    Giusca S; Mereles D; Ochs A; Buss S; André F; Seitz S; Riffel J; Fortner P; Andrulis M; Schönland S; Katus HA; Korosoglou G
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):879-888. PubMed ID: 28138817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of CMR for the differential diagnosis of cardiac masses.
    Pazos-López P; Pozo E; Siqueira ME; García-Lunar I; Cham M; Jacobi A; Macaluso F; Fuster V; Narula J; Sanz J
    JACC Cardiovasc Imaging; 2014 Sep; 7(9):896-905. PubMed ID: 25129516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging.
    Kassi M; Polsani V; Schutt RC; Wong S; Nabi F; Reardon MJ; Shah DJ
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1912-1922.e2. PubMed ID: 30551963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
    Altiok E; Tiemann S; Becker M; Koos R; Zwicker C; Schroeder J; Kraemer N; Schoth F; Adam D; Friedman Z; Marx N; Hoffmann R
    J Am Soc Echocardiogr; 2014 Mar; 27(3):249-57. PubMed ID: 24368027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.
    Chan AT; Plodkowski AJ; Pun SC; Lakhman Y; Halpenny DF; Kim J; Goldburg SR; Matasar MJ; Moskowitz CS; Gupta D; Steingart R; Weinsaft JW
    J Cardiovasc Magn Reson; 2017 Oct; 19(1):76. PubMed ID: 29025425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cardiac masses by CMR-strengths and pitfalls: a tertiary center experience.
    Tumma R; Dong W; Wang J; Litt H; Han Y
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):913-20. PubMed ID: 26838354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac tumors: the experience of a tertiary cardiology center.
    Giuşcă S; Jurcuţ R; Serban M; Popescu BA; Apetrei E; Ginghină C
    Rom J Intern Med; 2007; 45(4):333-9. PubMed ID: 18767408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac tumors: three decades of experience from a tertiary center: are we changing diagnostic work-up with new imaging tools?
    Mendes GS; Abecasis J; Ferreira A; Ribeiras R; Abecasis M; Gouveia R; Andrade MJ; Mendes M; Ramos S; Saraiva C; Neves JP
    Cardiovasc Pathol; 2020; 49():107242. PubMed ID: 32629212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours.
    Fussen S; De Boeck BW; Zellweger MJ; Bremerich J; Goetschalckx K; Zuber M; Buser PT
    Eur Heart J; 2011 Jun; 32(12):1551-60. PubMed ID: 21498848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
    Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity.
    Chan AT; Dinsfriend W; Kim J; Yum B; Sultana R; Klebanoff CA; Plodkowski A; Perez Johnston R; Ginsberg MS; Liu J; Kim RJ; Steingart R; Weinsaft JW
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):42. PubMed ID: 33814005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: an observational study.
    Caspar T; El Ghannudi S; Ohana M; Labani A; Lawson A; Ohlmann P; Morel O; De Mathelin M; Roy C; Gangi A; Germain P
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):551-559. PubMed ID: 27904982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac tumours in children.
    Ram SP; Malik AS
    Med J Malaysia; 1994 Mar; 49(1):96-9. PubMed ID: 8058000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac magnetic resonance imaging on heart failure patients referred to a tertiary advanced heart failure unit: improvements in diagnosis and management.
    Lum YH; McKenzie S; Brown M; Hamilton-Craig C
    Intern Med J; 2019 Feb; 49(2):203-211. PubMed ID: 30152581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses.
    Chan AT; Maya TR; Park C; Tak K; Liberman N; Jain RH; Park MJ; Park RY; Grizzard J; Kim G; Tap WD; Jessurun J; Liu J; Kim J; Steingart RM; Weinsaft JW
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):128-145. PubMed ID: 37410010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cardiac masses: magnetic resonance imaging versus transthoracic echocardiography.
    Narin B; Arman A; Arslan D; Simşek M; Narin A
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):69-74. PubMed ID: 20150010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.